% Expired Patents = 80.0

EPO Patents = 1

Forward Citations = 94

Loading Chart...

4 inventors (with patents filed for the assignee):

Sanjay Khare (5 out of 13 patents)

Michael Gresser (5 out of 5 patents)

Iqbal Grewal (5 out of 5 patents)

4. Rashid Syed (4 out of 5 patents)

5. Sanjay D Khare (0 patent)

5 patents: Sort by Forward Citations

1. 10259854 - Engineered antibody-interferon mutant fusion molecules (2019-04-16),

2. 9783589 - Engineered antibody-interferon fusion molecules for treatment of autoimmune diseases (2017-10-10),

3. 9534057 - Methods of treating tumors with engineered antibody-interferon mutant fusion molecules (2017-01-03),

4. 9534056 - Engineered TAA antibody-TNFSF member ligand fusion molecules (2017-01-03),

5. 8980267 - Engineered antibody-interferon mutant fusion molecules (2015-03-17),

Immungene Inc is a biotechnology company focused on developing immunotherapies for cancer treatment. Their innovative approach combines cutting-edge technologies to target specific cancer cells while minimizing damage to healthy tissue. Through extensive research and clinical trials, Immungene is dedicated to advancing the field of cancer immunotherapy and improving outcomes for patients.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

5 Patents

#50 in Camarillo, CA

#12,038 in California

#51,502 in US

Camarillo, CA, United States of America

Immungene Inc